Table 2 Disease status at trial entry and previous treatments

From: Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma

Previous treatment details

 

Prior lines of chemotherapy

 

Median (range)

2 (1–5)

 1

18

 2

12

 3⩾

11

Prior high-dose chemotherapy

 

 Yes

6

 No

35

Prior radiotherapy

 

 Yes

18

 No

23

Prior rituximab

 

 Yes

7

 No

34

Disease status

 

 Primary progressivea

8 patients

 1st relapse

9 patients

 2nd relapse

11 patients

 3rd and subsequent relapse

13 patients

Remission duration b

 

 < 1 year

29 patients

 > 1 year

12 patients

Chemosensitivec

22

Chemoresistantd

19

  1. aDisease progression during or within 90 days of completion of induction treatment.
  2. bDisease-free interval from end of last treatment till relapse.
  3. cResponse to prior chemotherapy lasting greater than 90 days from completion of treatment.
  4. dDisease progression during or within 90 days of completion of last chemotherapy.
Back to article page